Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Weight Loss 1Pancreatic Neoplasms 1Cachexia 1Anorexia 1

Interventions

Blood Specimen Collection 3Standard of Care 2Diet Therapy 2telotristat ethyl 1remune 1ostarine 1nabiximols 1irinotecan sucrosofate 1dermcidin 1bermekimab 1anamorelin 1Resistance Training 1Powders 1Omacor 1Olanzapine 1Nutritional Status 1Melatonin 1Megestrol Acetate 1Infliximab 1Immunologic Techniques 1Ibuprofen 1Gemcitabine 1Fluorouracil 1Exercise 1Enteral Nutrition 1Cyproheptadine 1Curcumin 1Calorimetry, Indirect 1Calorimetry 1Body Height 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cachexia × anamorelin × Gastrointestinal × Clear all
NCT04844970 2025-11-17

Anamorelin Study for Advanced Pancreatic Cancer

Lahey Clinic

Phase 2 Terminated
4 enrolled 12 charts
Gastrointestinal

Anorexia, Cachexia, Pancreatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡